1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cell Immortalization Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Stem Cell Therapy 1.2.3 Cell Transplantation 1.2.4 Drug Transport 1.2.5 Others 1.3 Market by Application 1.3.1 Global Cell Immortalization Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Pharmaceutical and Biopharmaceutical Company 1.3.3 Research Laboratory 1.3.4 Hospital 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cell Immortalization Market Perspective (2017-2028) 2.2 Cell Immortalization Growth Trends by Region 2.2.1 Cell Immortalization Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Cell Immortalization Historic Market Size by Region (2017-2022) 2.2.3 Cell Immortalization Forecasted Market Size by Region (2023-2028) 2.3 Cell Immortalization Market Dynamics 2.3.1 Cell Immortalization Industry Trends 2.3.2 Cell Immortalization Market Drivers 2.3.3 Cell Immortalization Market Challenges 2.3.4 Cell Immortalization Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cell Immortalization Players by Revenue 3.1.1 Global Top Cell Immortalization Players by Revenue (2017-2022) 3.1.2 Global Cell Immortalization Revenue Market Share by Players (2017-2022) 3.2 Global Cell Immortalization Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cell Immortalization Revenue 3.4 Global Cell Immortalization Market Concentration Ratio 3.4.1 Global Cell Immortalization Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cell Immortalization Revenue in 2021 3.5 Cell Immortalization Key Players Head office and Area Served 3.6 Key Players Cell Immortalization Product Solution and Service 3.7 Date of Enter into Cell Immortalization Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cell Immortalization Breakdown Data by Type 4.1 Global Cell Immortalization Historic Market Size by Type (2017-2022) 4.2 Global Cell Immortalization Forecasted Market Size by Type (2023-2028) 5 Cell Immortalization Breakdown Data by Application 5.1 Global Cell Immortalization Historic Market Size by Application (2017-2022) 5.2 Global Cell Immortalization Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Cell Immortalization Market Size (2017-2028) 6.2 North America Cell Immortalization Market Size by Country (2017-2022) 6.3 North America Cell Immortalization Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Cell Immortalization Market Size (2017-2028) 7.2 Europe Cell Immortalization Market Size by Country (2017-2022) 7.3 Europe Cell Immortalization Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Cell Immortalization Market Size (2017-2028) 8.2 Asia-Pacific Cell Immortalization Market Size by Country (2017-2022) 8.3 Asia-Pacific Cell Immortalization Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Cell Immortalization Market Size (2017-2028) 9.2 Latin America Cell Immortalization Market Size by Country (2017-2022) 9.3 Latin America Cell Immortalization Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cell Immortalization Market Size (2017-2028) 10.2 Middle East & Africa Cell Immortalization Market Size by Country (2017-2022) 10.3 Middle East & Africa Cell Immortalization Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 GeneCopoeia 11.1.1 GeneCopoeia Company Detail 11.1.2 GeneCopoeia Business Overview 11.1.3 GeneCopoeia Cell Immortalization Introduction 11.1.4 GeneCopoeia Revenue in Cell Immortalization Business (2017-2022) 11.1.5 GeneCopoeia Recent Development 11.2 Lonza 11.2.1 Lonza Company Detail 11.2.2 Lonza Business Overview 11.2.3 Lonza Cell Immortalization Introduction 11.2.4 Lonza Revenue in Cell Immortalization Business (2017-2022) 11.2.5 Lonza Recent Development 11.3 Thermo Fisher Scientific 11.3.1 Thermo Fisher Scientific Company Detail 11.3.2 Thermo Fisher Scientific Business Overview 11.3.3 Thermo Fisher Scientific Cell Immortalization Introduction 11.3.4 Thermo Fisher Scientific Revenue in Cell Immortalization Business (2017-2022) 11.3.5 Thermo Fisher Scientific Recent Development 11.4 JSR 11.4.1 JSR Company Detail 11.4.2 JSR Business Overview 11.4.3 JSR Cell Immortalization Introduction 11.4.4 JSR Revenue in Cell Immortalization Business (2017-2022) 11.4.5 JSR Recent Development 11.5 Valneva 11.5.1 Valneva Company Detail 11.5.2 Valneva Business Overview 11.5.3 Valneva Cell Immortalization Introduction 11.5.4 Valneva Revenue in Cell Immortalization Business (2017-2022) 11.5.5 Valneva Recent Development 11.6 Sartorius 11.6.1 Sartorius Company Detail 11.6.2 Sartorius Business Overview 11.6.3 Sartorius Cell Immortalization Introduction 11.6.4 Sartorius Revenue in Cell Immortalization Business (2017-2022) 11.6.5 Sartorius Recent Development 11.7 Merck 11.7.1 Merck Company Detail 11.7.2 Merck Business Overview 11.7.3 Merck Cell Immortalization Introduction 11.7.4 Merck Revenue in Cell Immortalization Business (2017-2022) 11.7.5 Merck Recent Development 11.8 Applied Biological Materials Inc. 11.8.1 Applied Biological Materials Inc. Company Detail 11.8.2 Applied Biological Materials Inc. Business Overview 11.8.3 Applied Biological Materials Inc. Cell Immortalization Introduction 11.8.4 Applied Biological Materials Inc. Revenue in Cell Immortalization Business (2017-2022) 11.8.5 Applied Biological Materials Inc. Recent Development 11.9 InSCREENeX GmbH 11.9.1 InSCREENeX GmbH Company Detail 11.9.2 InSCREENeX GmbH Business Overview 11.9.3 InSCREENeX GmbH Cell Immortalization Introduction 11.9.4 InSCREENeX GmbH Revenue in Cell Immortalization Business (2017-2022) 11.9.5 InSCREENeX GmbH Recent Development 11.10 BioCat GmbH 11.10.1 BioCat GmbH Company Detail 11.10.2 BioCat GmbH Business Overview 11.10.3 BioCat GmbH Cell Immortalization Introduction 11.10.4 BioCat GmbH Revenue in Cell Immortalization Business (2017-2022) 11.10.5 BioCat GmbH Recent Development 11.11 Creative Biolabs 11.11.1 Creative Biolabs Company Detail 11.11.2 Creative Biolabs Business Overview 11.11.3 Creative Biolabs Cell Immortalization Introduction 11.11.4 Creative Biolabs Revenue in Cell Immortalization Business (2017-2022) 11.11.5 Creative Biolabs Recent Development 11.12 GenScript 11.12.1 GenScript Company Detail 11.12.2 GenScript Business Overview 11.12.3 GenScript Cell Immortalization Introduction 11.12.4 GenScript Revenue in Cell Immortalization Business (2017-2022) 11.12.5 GenScript Recent Development 11.13 Nucleus Biotech 11.13.1 Nucleus Biotech Company Detail 11.13.2 Nucleus Biotech Business Overview 11.13.3 Nucleus Biotech Cell Immortalization Introduction 11.13.4 Nucleus Biotech Revenue in Cell Immortalization Business (2017-2022) 11.13.5 Nucleus Biotech Recent Development 11.14 ALSTEM 11.14.1 ALSTEM Company Detail 11.14.2 ALSTEM Business Overview 11.14.3 ALSTEM Cell Immortalization Introduction 11.14.4 ALSTEM Revenue in Cell Immortalization Business (2017-2022) 11.14.5 ALSTEM Recent Development 11.15 Maxanim 11.15.1 Maxanim Company Detail 11.15.2 Maxanim Business Overview 11.15.3 Maxanim Cell Immortalization Introduction 11.15.4 Maxanim Revenue in Cell Immortalization Business (2017-2022) 11.15.5 Maxanim Recent Development 11.16 Bio-REV Singapore 11.16.1 Bio-REV Singapore Company Detail 11.16.2 Bio-REV Singapore Business Overview 11.16.3 Bio-REV Singapore Cell Immortalization Introduction 11.16.4 Bio-REV Singapore Revenue in Cell Immortalization Business (2017-2022) 11.16.5 Bio-REV Singapore Recent Development 11.17 MilliporeSigma 11.17.1 MilliporeSigma Company Detail 11.17.2 MilliporeSigma Business Overview 11.17.3 MilliporeSigma Cell Immortalization Introduction 11.17.4 MilliporeSigma Revenue in Cell Immortalization Business (2017-2022) 11.17.5 MilliporeSigma Recent Development 11.18 AcceGen 11.18.1 AcceGen Company Detail 11.18.2 AcceGen Business Overview 11.18.3 AcceGen Cell Immortalization Introduction 11.18.4 AcceGen Revenue in Cell Immortalization Business (2017-2022) 11.18.5 AcceGen Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cell Immortalization Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Stem Cell Therapy Table 3. Key Players of Cell Transplantation Table 4. Key Players of Drug Transport Table 5. Key Players of Others Table 6. Global Cell Immortalization Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Cell Immortalization Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Cell Immortalization Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Cell Immortalization Market Share by Region (2017-2022) Table 10. Global Cell Immortalization Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Cell Immortalization Market Share by Region (2023-2028) Table 12. Cell Immortalization Market Trends Table 13. Cell Immortalization Market Drivers Table 14. Cell Immortalization Market Challenges Table 15. Cell Immortalization Market Restraints Table 16. Global Cell Immortalization Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Cell Immortalization Market Share by Players (2017-2022) Table 18. Global Top Cell Immortalization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Immortalization as of 2021) Table 19. Ranking of Global Top Cell Immortalization Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Cell Immortalization Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Cell Immortalization Product Solution and Service Table 23. Date of Enter into Cell Immortalization Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Cell Immortalization Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Cell Immortalization Revenue Market Share by Type (2017-2022) Table 27. Global Cell Immortalization Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Cell Immortalization Revenue Market Share by Type (2023-2028) Table 29. Global Cell Immortalization Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Cell Immortalization Revenue Market Share by Application (2017-2022) Table 31. Global Cell Immortalization Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Cell Immortalization Revenue Market Share by Application (2023-2028) Table 33. North America Cell Immortalization Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Cell Immortalization Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Cell Immortalization Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Cell Immortalization Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Cell Immortalization Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Cell Immortalization Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Cell Immortalization Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Cell Immortalization Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Cell Immortalization Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Cell Immortalization Market Size by Country (2023-2028) & (US$ Million) Table 43. GeneCopoeia Company Detail Table 44. GeneCopoeia Business Overview Table 45. GeneCopoeia Cell Immortalization Product Table 46. GeneCopoeia Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 47. GeneCopoeia Recent Development Table 48. Lonza Company Detail Table 49. Lonza Business Overview Table 50. Lonza Cell Immortalization Product Table 51. Lonza Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 52. Lonza Recent Development Table 53. Thermo Fisher Scientific Company Detail Table 54. Thermo Fisher Scientific Business Overview Table 55. Thermo Fisher Scientific Cell Immortalization Product Table 56. Thermo Fisher Scientific Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 57. Thermo Fisher Scientific Recent Development Table 58. JSR Company Detail Table 59. JSR Business Overview Table 60. JSR Cell Immortalization Product Table 61. JSR Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 62. JSR Recent Development Table 63. Valneva Company Detail Table 64. Valneva Business Overview Table 65. Valneva Cell Immortalization Product Table 66. Valneva Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 67. Valneva Recent Development Table 68. Sartorius Company Detail Table 69. Sartorius Business Overview Table 70. Sartorius Cell Immortalization Product Table 71. Sartorius Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 72. Sartorius Recent Development Table 73. Merck Company Detail Table 74. Merck Business Overview Table 75. Merck Cell Immortalization Product Table 76. Merck Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 77. Merck Recent Development Table 78. Applied Biological Materials Inc. Company Detail Table 79. Applied Biological Materials Inc. Business Overview Table 80. Applied Biological Materials Inc. Cell Immortalization Product Table 81. Applied Biological Materials Inc. Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 82. Applied Biological Materials Inc. Recent Development Table 83. InSCREENeX GmbH Company Detail Table 84. InSCREENeX GmbH Business Overview Table 85. InSCREENeX GmbH Cell Immortalization Product Table 86. InSCREENeX GmbH Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 87. InSCREENeX GmbH Recent Development Table 88. BioCat GmbH Company Detail Table 89. BioCat GmbH Business Overview Table 90. BioCat GmbH Cell Immortalization Product Table 91. BioCat GmbH Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 92. BioCat GmbH Recent Development Table 93. Creative Biolabs Company Detail Table 94. Creative Biolabs Business Overview Table 95. Creative Biolabs Cell ImmortalizationProduct Table 96. Creative Biolabs Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 97. Creative Biolabs Recent Development Table 98. GenScript Company Detail Table 99. GenScript Business Overview Table 100. GenScript Cell ImmortalizationProduct Table 101. GenScript Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 102. GenScript Recent Development Table 103. Nucleus Biotech Company Detail Table 104. Nucleus Biotech Business Overview Table 105. Nucleus Biotech Cell ImmortalizationProduct Table 106. Nucleus Biotech Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 107. Nucleus Biotech Recent Development Table 108. ALSTEM Company Detail Table 109. ALSTEM Business Overview Table 110. ALSTEM Cell ImmortalizationProduct Table 111. ALSTEM Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 112. ALSTEM Recent Development Table 113. Maxanim Company Detail Table 114. Maxanim Business Overview Table 115. Maxanim Cell ImmortalizationProduct Table 116. Maxanim Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 117. Maxanim Recent Development Table 118. Bio-REV Singapore Company Detail Table 119. Bio-REV Singapore Business Overview Table 120. Bio-REV Singapore Cell ImmortalizationProduct Table 121. Bio-REV Singapore Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 122. Bio-REV Singapore Recent Development Table 123. MilliporeSigma Company Detail Table 124. MilliporeSigma Business Overview Table 125. MilliporeSigma Cell ImmortalizationProduct Table 126. MilliporeSigma Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 127. MilliporeSigma Recent Development Table 128. AcceGen Company Detail Table 129. AcceGen Business Overview Table 130. AcceGen Cell ImmortalizationProduct Table 131. AcceGen Revenue in Cell Immortalization Business (2017-2022) & (US$ Million) Table 132. AcceGen Recent Development Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Global Cell Immortalization Market Share by Type: 2021 VS 2028 Figure 2. Stem Cell Therapy Features Figure 3. Cell Transplantation Features Figure 4. Drug Transport Features Figure 5. Others Features Figure 6. Global Cell Immortalization Market Share by Application in 2021 & 2028 Figure 7. Pharmaceutical and Biopharmaceutical Company Case Studies Figure 8. Research Laboratory Case Studies Figure 9. Hospital Case Studies Figure 10. Other Case Studies Figure 11. Cell Immortalization Report Years Considered Figure 12. Global Cell Immortalization Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Cell Immortalization Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Cell Immortalization Market Share by Region: 2021 VS 2028 Figure 15. Global Cell Immortalization Market Share by Players in 2021 Figure 16. Global Top Cell Immortalization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Immortalization as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Cell Immortalization Revenue in 2021 Figure 18. North America Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. North America Cell Immortalization Market Share by Country (2017-2028) Figure 20. United States Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Cell Immortalization Market Share by Country (2017-2028) Figure 24. Germany Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Cell Immortalization Market Share by Region (2017-2028) Figure 32. China Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Japan Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. South Korea Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Southeast Asia Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. India Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Australia Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Cell Immortalization Market Share by Country (2017-2028) Figure 40. Mexico Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Brazil Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Cell Immortalization Market Share by Country (2017-2028) Figure 44. Turkey Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Saudi Arabia Cell Immortalization Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. GeneCopoeia Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 47. Lonza Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 49. JSR Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 50. Valneva Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 51. Sartorius Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 52. Merck Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 53. Applied Biological Materials Inc. Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 54. InSCREENeX GmbH Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 55. BioCat GmbH Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 56. Creative Biolabs Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 57. GenScript Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 58. Nucleus Biotech Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 59. ALSTEM Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 60. Maxanim Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 61. Bio-REV Singapore Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 62. MilliporeSigma Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 63. AcceGen Revenue Growth Rate in Cell Immortalization Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

GeneCopoeia Lonza Thermo Fisher Scientific JSR Valneva Sartorius Merck Applied Biological Materials Inc. InSCREENeX GmbH BioCat GmbH Creative Biolabs GenScript Nucleus Biotech ALSTEM Maxanim Bio-REV Singapore MilliporeSigma AcceGen